Image
Point-of-Careā„¢ 201

Updates on Chronic Rhinosinusitis with Nasal Polyps

Evolving Best Practices for Patient Management

Clinical Practice Guidelines

American Thoracic Society —An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Dweik RA, et al. Am J Respir Crit Care Med. 2011;184(5):602-615.

International Consensus Statement on Allergy and Rhinology: Rhinosinusitis.

Orlandi RR, et al. Int Forum Allergy Rhinol. 2016;6(suppl 1):S22-S209.

American Academy of Otolaryngology-Head and Neck Surgery—Clinical practice guideline (update): adult sinusitis.

Rosenfeld RM, et al. Otolaryngol Head Neck Surg. 2015;152(suppl 2):S1-S39.

EUFOREA consensus on biologics for CRSwNP with or without asthma.

Fokkens WJ, et al. Allergy. 2019;74(12):2312-2319.

Chronic rhinosinusitis with nasal polyps.

Hopkins C. N Engl J Med. 2019;381(1):55-63.

Patient Resources

Asthma and Allergy Foundation of America (AAFA)

AAFA is dedicated to improving the quality of life for people with asthma and allergic diseases including nasal polyps through education, advocacy, and research.

American Academy of Asthma, Allergy, and Immunology (AAAAI)

AAAAI is dedicated to the advancement of the knowledge and practice of allergy, asthma and immunology for optimal patient care.

Suggested Readings

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.

Bachert C, et al. Lancet. 2019;394(10209):1638-1650.

Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial.

Bachert C, et al. JAMA. 2016;315(5):469-479.

Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.

Gevaert P, et al. J Allergy Clin Immunol. 2020;S0091-6749(20)30752-1. [E-pub ahead of print.]

Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology.

Dietz de Loos D, et al. J Allergy Clin Immunol. 2019;143(3):1207-1214.

Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps.

Bhattacharyya N, et al. Laryngoscope. 2019:129(9):1969-1975.

Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.

Akdis CA, et al. J Allergy Clin Immunol. 2013;131(6):1479-1490.

Clinical research needs for the management of chronic rhinosinusitis with nasal polyps in the new era of biologics: a National Institute of Allergy and Infectious Diseases workshop.

Naclerio R, et al. J Allergy Clin Immunol Pract. 2020;8(5):1532-1549.

Biologics for chronic rhinosinusitis with nasal polyps.

Bachert C et al. Allergy Clin Immunol. 2020 ;145(3):725-739.

A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps.

Kern RC, et al. Int Forum Allergy Rhinol. 2018;8(4):471-481.

NAVIGATE II: randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis.

Leopold DA, et al. J Allergy Clin Immunol. 2019;143(1):126-134.

Current trends in topical therapies for chronic rhinosinusitis: update and literature review.

Varshney R, Lee JT. Expert Opin Drug Deliv. 2017;14(2):257-271.

Efficacy of fluticasone exhalation delivery system in the management of chronic rhinosinusitis: what is the evidence?

Kuan EC, et al. Int Forum Allergy Rhinol. 2019;9(S1):S16-S21.

Activity
Updates on Chronic Rhinosinusitis With Nasal Polyps

Evolving Best Practices for Patient Management

Relevant Resources

Chronic Obstructive Pulmonary Disease, Asthma, or Both

Differential Diagnosis and Comprehensive Management Strategies

Improving Outcomes in Chronic Obstructive Pulmonary Disease

Optimizing Maintenance Therapy Across Healthcare Settings

Clearing the Air

Improving Outcomes for Patients with COPD

Comprehensive Management of Chronic Obstructive Pulmonary Disease

Collaborative Approaches to Guideline-Concordant Patient Care

Clinical Updates in the Management of Severe Asthma

New Strategies for Individualizing Long-term Care

Improving Outcomes in Severe Asthma

A New Era in Precision Medicine

Caring for Patients with Severe Asthma

Evolving Best Practices to Optimize Outcomes

Clinical Issues in Severe Asthma

Consensus and Controversies on the Road to Precision Medicine

Breathing Life Into COPD Management

Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care

Clinical Issues in Severe Asthma

Debates and Discussions About Personalizing Patient Management

Advancing the Care of Severe Asthma

Differential Diagnosis, Multidisciplinary Management, and Patient Engagement

Focusing on Patients With Severe Asthma

From Guideline Recommendations to Daily Clinical Decision-Making

Clearing the Air in Severe Asthma Management

Improving Patient Outcomes Through Shared Clinical Decision Making

Clearing the Air in Severe Asthma Management

Improving Patient Outcomes Through Shared Clinical Decision Making

Marching Forward in Atopic Dermatitis

Digging Deep on Shared Decision-Making

Airing It Out

A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyposis

COPD in Managed Care

The Clinical and Utilization Benefits of Exacerbation Prevention

Finding the Right Path in Severe Asthma

Mechanistic Insights and Emerging Treatment Options

COPD Cases and Conversations

A Focus on Exacerbation Prevention

Demystifying New Evidence for COPD Management

Best Practices for Primary Care